Franklin Gaylis, MD, FACS
Franklin Gaylis, MD, FACS, is a urology consultant at Labcorp Drug Development. He also serves as executive medical director of Unio Health Partners (UHP), the largest urology group in California, and as a voluntary professor of urology at the University of California, San Diego.
Dr. Gaylis is a fellow of the American College of Surgeons, member of the American Urological Association and diplomat of the American Board of Urology. He lectures nationally and internationally on the subject of medical quality and implementation science and is considered a leader in the field. His research has been published in clinical journals such as Urology, Journal of Urology, Urology Practice, American Journal of Medical Quality and the New England Journal of Medicine. Dr. Gaylis' practice of more than 30 years has been focused on treating early- and late-stage prostate and bladder cancer including surgical procedures as well as clinical trials, Phases I-IV. He has participated in numerous clinical trials over the past 30 years, serving as PI in many, and has 40 publications, 30 of which he is first author. Dr. Gaylis has a deep interest in data mining from the EMR and oversees UHP's healthcare informatics program. He has experience with "big data" analytics and is exploring the feasibility for developing synthetic/external controls in Urology at Labcorp. Dr. Gaylis provides urological guidance for therapeutics, diagnostics and biomarker clinical trials and has conducted several advisory boards for sponsors seeking guidance regarding protocols in development. He joined in Labcorp in 2020.